Greenberg Traurig’s Tel Aviv office is collaborating with partners BNY Mellon and H.C. Wainwright & Co. LLC to host a morning roundtable focused on capital markets options for the life
Continue Reading Tel Aviv Office to Host Capital Markets Roundtable for the Life Sciences Industry

It is commonplace to note the vigorous market for inbound investment and M&A transactions involving high-tech companies in Israel. Hardly a week goes by without a deal. Between 2002-2011, Israeli high-tech companies raised $15 billion from investors, and in the same period owners received more than $37 billion in proceeds from M&A and IPO exits. There were approximately 85 acquisitions in 2011 alone. These trends have continued into 2012.
Continue Reading A View from Israel: Expect More Activity From Buyout Funds and Distressed Players